What We Do
Defective Medical Products
- Medicines
- Accutane Lawsuit
- AMO Complete Moistureplus Recall
- Apothecure Colchicine Lawsuit
- Baxter Heparin Recall and Lawsuit
- Bayer Lawsuit
- Bismacine Chromacine
- Botox
- Carbinoxamine
- Chromium Poisoning (Toxicity)
- Colchicine Recall Lawyer
- Colistimethate Lawsuit Lawyer
- Compounding Pharmacy Error
- Edetate Disodium
- Fentanyl
- Fentanyl Lawsuit
- Fentanyl Patch Recall
- Fentora
- Fleet Lawsuit - Phosphate Nephropathy
- Fosamax Osteonecrosis Jaw
- Ketek Liver Failure
- Ortho Evra Birth Control Patch
- Pharmacist Malpractice
- Promethazine
- Rocephin Death
- Selenium Poisoning (Toxicity)
- Topical Anesthetic
- Total Body Formula Recall and Lawsuit
- Trasylol and Kidney Failure
- Trasylol - Lawyer and Lawsuit
- Trasylol Recall
- Tysabri Lawsuit - No Recall
- Zelnorm Heart Attack Stroke Lawsuit
- Medical Equipment
- Medtronic Defibrillator Leads
- Medtronic Lawsuit
- Medtronic Lawyer
- Guidant Recalls
- Free Guidant Recall Consultation
- Guidant Ancure
- Guidant Lawsuit Recall
- Guidant Pacemaker Defibrillator Defect
- Guidant Pacemaker Recall
- FDA Pacemaker Defibrillator Statement
- Infusion Pump
- FDA Recalls
- News & Topics
- Archives
Welcome to Pritzker | Ruohonen
Ortho Evra and Pulmonary Embolism Caused by Ortho Evra Blood Clot - Venous Thromboembolism (VTE)
| ORTHO EVRA INFORMATION |
| Ortho Evra Blood Clot - FDA |
| Ortho Evra Heart Attack |
| Ortho Evra Pulmonary Embolism |
| Ortho Evra Stroke |
| Ortho Evra Lawsuit |
Pritzker | Ruohonen, a nationally-recognized product liability law firm, isinvestigating cases involving Ortho Evra birth control patches manufactured by Ortho McNeil Pharmaceuticals, a division of Johnson and Johnson. For Johnson and Johnson lawsuit information, contact Pritzker | Ruohonen toll free at 1-888-377-8900 or fill out the firm's free case consultation form.
Below is the FDA notification of an update to the the label on the Ortho Evra birth control patch because of the risk of pulmonary embolism, blockage of the pulmonary artery (or one of its branches) caused by blood clot, specifically venous thromboembolism (VTE).
FDA Approves Update to Label on Ortho Evra Birth Control Patch Due to Risk of Pulmonary Embolism
The U.S. Food and Drug Administration (FDA) today approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills. VTE can lead to pulmonary embolism.
The label changes are based on a study conducted by the Boston Collaborative Drug Surveillance Program (BCDSP) on behalf of Johnson and Johnson. The patch was studied in women aged 15-44. These recent findings support an earlier study that also said women in this group were at higher risk for VTE [Ortho Evra blood clot].
"For women that choose to use contraceptives, it is important that they thoroughly discuss with their health care providers the risks and benefits involved," said Janet Woodcock, M.D., the FDA's deputy commissioner for scientific and medical programs, chief medical officer, and acting director of the Center for Drug Evaluation and Research.
"This is an example of FDA working in tandem with the drug manufacturer to keep the public informed of new safety data and epidemiological studies that may impact health decisions about the use of FDA approved products."
In September 2006, FDA revised the label for Ortho Evra to warn women of the risk of VTE [Ortho Evra blood clot] based on two epidemiology studies. One study, conducted by i3 Ingenix, showed that some women using the patch were at a two-fold greater risk of developing VTE. The other study, conducted by BCDSP, showed they were not at increased risk compared to women using birth control pills containing 30-35 micrograms of estrogen and the progestin norgestimate.
Ortho Evra is a prescription patch that releases ethinyl estradiol (an estrogen hormone) and norelgestromin (a progestin hormone) through the skin into the blood stream. Because the hormones are processed by the body differently than hormones from birth control pills, women using the product will be exposed to about 60 percent more estrogen than if they were using typical birth control pills containing 35 micrograms of estrogen. Increased levels of estrogen may increase the risk of side effects, including VTE [Ortho Evra blood clot]. Women should discuss with their health care provider the possible increased risk of VTE with Ortho Evra, which is applied once a week, and balance this risk against the increased chance of pregnancy if women do not take their birth control pill daily.
The FDA believes that Ortho Evra is a safe and effective method of contraception when used according to the labeling, which recommends that women with concerns or risk factors for serious blood clots talk with their health care provider about using Ortho Evra versus other contraceptive options.
The Ortho Evra Contraceptive Transdermal Patch is manufactured by Ortho McNeil Pharmaceuticals, a division of Johnson and Johnson.
Pritzker | Ruohonen is a national law firm and represents people injured by defective medical products and the families of people whose deaths were caused by defective medical products. We have been contacted by several women and families regarding the Ortho Evra birth control patch, Ortho Evra blood clots and a Johnson and Johnson lawsuit..
We have gained a national reputation, and attorneys at our firm have been interviewed by The New York Times, The Wall Street Journal, Lawyers USA and other publications. In recognition of their accomplishments, attorneys at our firm have been named “Super Lawyers” by Law & Politics magazine and been listed in The Best Lawyers in America. They are sought-after speakers and regularly conduct seminars for other lawyers on complex legal issues. Contact us about Ortho Evra blood clots, Ortho Evra and pulmanary embolism and a Johnson and Johnson lawsuit.
Free Case Consultation
Firm News
Fred Pritzker Listed in The Best Lawyers in America
Fred Pritzker has been notified that he will again be listed in The Best Lawyers in America for his work in personal injury litigation.
Pain and Suffering
Rich Ruohonen recently chaired a legal seminar on obtaining compensation for pain and suffering in a personal injury case. Rich uses his knowledge, experience, and reputation to maximize recoveries for clients.
Medtronic Recall and Medtronic Lawsuit
FDA has annonced a Medtronic Spring Fidelis defibrillator lead recall. Two of our clients with defective Medtronic leads were shocked over twenty times before medical professionals were able to turn off the defibrillator.
Fleet Lawsuit
We are representing several people who experienced kidney failure (acute phosphate nephropathy) after use of Fleet Phospho-soda solution or Fleet Accu-Prep solution for bowel cleansing.
Ortho Evra Lawsuit: Ortho Evra Birth Control Patch
The Ortho Evra birth control patch has been linked to an increased risk of blood clots that can lead to pulmonary embolism, stroke and heart attack.
Trasylol Recall
Bayer has agreed to a marketing suspension of Trasylol, a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.
Fentanyl Lawsuit and Fentanyl Recall
There have been a number of recalls regarding fentanyl due to the risk of a fentanyl overdose.
Fosamax and Osteonecrosis
Several cases of bisphosphonate-associated osteonecrosis of the jaw have been associated with the use of oral bisphosphonates, including Fosamax®, Actonel®, and other medications.